Literature DB >> 17014913

Macrophages in human fallopian tube and ovarian epithelial inclusion cysts.

M Gaytán1, C Morales, C Bellido, J E Sánchez-Criado, F Gaytán.   

Abstract

Epithelial inclusion cysts (EICs) are considered a preferential site for ovarian carcinogenesis. Local inflammation, associated to ovulatory wound repair and epithelial inflammatory conditions, facilitates EIC formation and involves activation of macrophages. The aim of this study was to analyse the presence and numbers of macrophages in the ovarian surface epithelium (OSE), in EICs, and in the fallopian tubes, as tubal metaplasia is a common finding in EICs. Immunohistochemical analysis of macrophages was performed in 25 fallopian tubes in different phases of the menstrual cycle, and in 30 ovaries showing EICs from cycling and postmenopausal women. In the fallopian tube, macrophages were abundant and underwent cyclic changes during the menstrual cycle, being particularly abundant within the epithelium at early and mid-luteal phases. Macrophages were not found in the normal OSE. However, OSE areas and EICs showing tubal metaplasia were invariably associated with infiltration by abundant macrophages. Macrophages were present among epithelial cells, infiltrating the cyst wall, as well as free in the cyst lumen. No significant differences existed between follicular and luteal phases of the cycle, or between cycling and postmenopausal women. This study has demonstrated that macrophages are associated with metaplastic EICs, and raises the possibility that these cells contribute to the particular microenvironment of EICs through secretion of cytokines and growth factors that may reach bioactive concentrations in the confined space of the EICs.

Entities:  

Mesh:

Year:  2006        PMID: 17014913     DOI: 10.1016/j.jri.2006.06.002

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  7 in total

1.  The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer.

Authors:  Shelby M King; Tyvette S Hilliard; Lucia Y Wu; Randal C Jaffe; Asgerally T Fazleabas; Joanna E Burdette
Journal:  Endocr Relat Cancer       Date:  2011-09-20       Impact factor: 5.678

Review 2.  The immune system in the pathogenesis of ovarian cancer.

Authors:  Bridget Charbonneau; Ellen L Goode; Kimberly R Kalli; Keith L Knutson; Melissa S Derycke
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

Review 3.  Immune physiology in tissue regeneration and aging, tumor growth, and regenerative medicine.

Authors:  Antonin Bukovsky; Michael R Caudle; Ray J Carson; Francisco Gaytán; Mahmoud Huleihel; Andrea Kruse; Heide Schatten; Carlos M Telleria
Journal:  Aging (Albany NY)       Date:  2009-02-13       Impact factor: 5.682

4.  Serous tubal intraepithelial carcinoma, chronic fallopian tube injury, and serous carcinoma development.

Authors:  Karin Malmberg; Charlotta Klynning; Angelique Flöter-Rådestad; Joseph W Carlson
Journal:  Virchows Arch       Date:  2016-03-22       Impact factor: 4.064

5.  Lymphoid and myeloid cell populations in the non-pregnant human Fallopian tube and in ectopic pregnancy.

Authors:  J L V Shaw; P Fitch; J Cartwright; G Entrican; J Schwarze; H O D Critchley; A W Horne
Journal:  J Reprod Immunol       Date:  2011-03-17       Impact factor: 4.054

6.  Expression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers.

Authors:  Daniel J O'Shannessy; Elizabeth B Somers; Li-Chong Wang; Hongwei Wang; Ruby Hsu
Journal:  J Ovarian Res       Date:  2015-05-14       Impact factor: 4.234

7.  Macrophage-derived extracellular vesicles regulate follicular activation and improve ovarian function in old mice by modulating local environment.

Authors:  Yue Xiao; Xiaoxu Peng; Yue Peng; Chi Zhang; Wei Liu; Weijie Yang; Xiaowei Dou; Yuying Jiang; Yaxuan Wang; Shuo Yang; Wenpei Xiang; Tinghe Wu; Jing Li
Journal:  Clin Transl Med       Date:  2022-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.